Joerg Faber

4.1k total citations · 2 hit papers
42 papers, 2.9k citations indexed

About

Joerg Faber is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Joerg Faber has authored 42 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Hematology. Recurrent topics in Joerg Faber's work include Acute Myeloid Leukemia Research (8 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Neuroblastoma Research and Treatments (4 papers). Joerg Faber is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Neuroblastoma Research and Treatments (4 papers). Joerg Faber collaborates with scholars based in Germany, United States and Netherlands. Joerg Faber's co-authors include Scott A. Armstrong, Andrei V. Krivtsov, Zhaohui Feng, Matthew C. Stubbs, Andrew L. Kung, D. Gary Gilliland, David Twomey, Jason Levine, Jing Wang and William C. Hahn and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

Joerg Faber

37 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

2006 1.0k citations Andrei V. Krivtsov, Zhaohui Feng et al. profile →
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L

2011 642 citations Kathrin M. Bernt, Nan Zhu et al. Cancer Cell profile →

Peers

Countries citing papers authored by Joerg Faber

Since Specialization

Citations

This map shows the geographic impact of Joerg Faber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Faber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Faber more than expected).

Fields of papers citing papers by Joerg Faber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joerg Faber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Faber. The network helps show where Joerg Faber may publish in the future.

Co-authorship network of co-authors of Joerg Faber

This figure shows the co-authorship network connecting the top 25 collaborators of Joerg Faber. A scholar is included among the top collaborators of Joerg Faber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joerg Faber. Joerg Faber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ganglioside Profiling Uncovers Distinct Patterns in High-Risk Neuroblastoma 2025 ·International Journal of Molecular Sciences ·Claudia Paret, Arthur Wingerter, Larissa Seidmann, (unknown), (unknown), (unknown), (unknown), Chiara Brignole, Fabio Pastorino, (unknown), Khalifa El Malki, Wilfried Roth, Roger Sandhoff, Joerg Faber	0
2	The Chimeric Antigen Receptor T Cell Target Claudin 6 Is a Marker for Early Organ-Specific Epithelial Progenitors and Is Expressed in Some Pediatric Solid Tumor Entities 2025 ·Cancers ·Larissa Seidmann, Arthur Wingerter, Marie Oliver Metzig, (unknown), Khalifa El Malki, (unknown), (unknown), (unknown), Thomas Kindler, Mark Laible, (unknown), Nicole Henninger, Alexandra Russo, Olaf Beck, Francesca Alt, (unknown), Wilfried Roth, Claudia Paret, Joerg Faber	0
3	Sources of vulnerability and ethical challenges in qualitative research with pediatric cancer patients 2025 ·Childhood ·(unknown), Norbert W. Paul, Marie A. Neu, Joerg Faber	0
4	Childhood cancer patients' experiences of a structured exercise program. A qualitative study using reflexive thematic analysis 2025 ·Frontiers in Pediatrics ·(unknown), Norbert W. Paul, (unknown), Francesca Alt, Marie A. Neu, Joerg Faber	1
5	Naxitamab-related adverse events within and across treatment cycles in patients with relapsed/refractory (R/R) high-risk neuroblastoma. 2024 ·Journal of Clinical Oncology ·Jaume Mora, Godfrey Chi Fung Chan, Daniel A. Morgenstern, Loredana Amoroso, Karsten Nysom, Joerg Faber, Arthur Wingerter, (unknown), (unknown), James Eldridge, Karen Tornøe, Maria Düring, Brian H. Kushner	2
6	Physical Activity as a Treatment for Cancer-Related Fatigue in Children, Adolescents and Young Adults: A Systematic Review 2023 ·Children ·(unknown), (unknown), (unknown), Marie A. Neu, (unknown), (unknown), Perikles Simon, Joerg Faber	4
7	129P Naxitamab efficacy in patients with refractory/relapsed high-risk neuroblastoma and bone metastases as assessed by Curie score 2023 ·Immuno-Oncology Technology ·Brian H. Kushner, Jaume Mora, Gcf Chan, Daniel A. Morgenstern, Loredana Amoroso, (unknown), Joerg Faber, Arthur Wingerter, (unknown), (unknown), (unknown), Karen Tornøe	1
8	Multivariate analysis on complications of central venous access devices in children with cancer and severe disease influenced by catheter tip position and vessel insertion site (A STROBE-compliant study) 2020 ·Surgical Oncology ·Sarah Hofmann, Jan Goedeke, (unknown), Alicia Poplawski, Oliver J. Muensterer, Joerg Faber, Olaf Beck	5
9	Novel loss of function mutation in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor 2017 ·Child s Nervous System ·Alexandra Russo, Marie A. Neu, Johanna Theruvath, (unknown), Arthur Wingerter, (unknown), (unknown), Joerg Faber	6
10	Prospective analysis of long-term renal function in survivors of childhood Wilms tumor 2017 ·Pediatric Nephrology ·Marie A. Neu, Alexandra Russo, Arthur Wingerter, Francesca Alt, Johanna Theruvath, Khalifa El Malki, (unknown), (unknown), Johannes Lotz, Raimund Stein, Rolf Beetz, Joerg Faber	31
11	Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience 2016 ·Bone Marrow Transplantation ·André Willasch, Emilia Salzmann‐Manrique, (unknown), (unknown), Joerg Faber, (unknown), Hermann Kreyenberg, (unknown), Sabine Huenecke, (unknown), Melanie Bremm, (unknown), Matthias Merker, Evelyn Ullrich, Shahrzad Bakhtiar, Eva Rettinger, Andrea Jarisch, Jan Soerensen, Thomas Klingebiel, Peter Bader	18
12	MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L breakdown → 2011 ·Cancer Cell ·Kathrin M. Bernt, Nan Zhu, Amit Sinha, Sridhar Vempati, Joerg Faber, Andrei V. Krivtsov, Zhaohui Feng, (unknown), (unknown), Lars Bullinger, Roy M. Pollock, Victoria M. Richon, Andrew L. Kung, Scott A. Armstrong	642
13	MLL -Rearranged B Lymphoblastic Leukemias Selectively Express the Immunoregulatory Carbohydrate-Binding Protein Galectin-1 2010 ·Clinical Cancer Research ·Przemysław Juszczyński, Scott J. Rodig, Jing Ouyang, Evan A. O’Donnell, Kunihiko Takeyama, Wojciech Młynarski, (unknown), Tomasz Szczepański, (unknown), Andrei V. Krivtsov, Joerg Faber, Amit Sinha, Gabriel A. Rabinovich, Scott A. Armstrong, Jeffery L. Kutok, Margaret A. Shipp	28
14	H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias 2008 ·Cancer Cell ·Andrei V. Krivtsov, Zhaohui Feng, Madeleine E. Lemieux, Joerg Faber, Sridhar Vempati, Amit Sinha, Xiaobo Xia, Jonathan L. Jesneck, Adrian P. Bracken, Lewis B. Silverman, Jeffery L. Kutok, Andrew L. Kung, Scott A. Armstrong	396
15	Rapid detection of common pathogenic Aspergillus species by a novel real‐time PCR approach 2008 ·Mycoses ·Joerg Faber, (unknown), Nicole Henninger, Fred Zepp, (unknown)	11
16	Age-Dependent Association of Human Mannose-Binding Lectin Mutations With Susceptibility to Invasive Meningococcal Disease in Childhood 2007 ·The Pediatric Infectious Disease Journal ·Joerg Faber, (unknown), Adam Finn, Craig Murdoch, Werner Zenz, Pirmin Habermehl, Claudius U. Meyer, Bernhard Zabel, Heinz-J. Schmitt, Fred Zepp, Markus Knuf	36
17	Defining Leukemia Stem Cells in MLL-Translocated Leukemias: Implications for Novel Therapeutic Strategies 2007 ·Klinische Pädiatrie ·Joerg Faber, (unknown)	1
18	Some Complications of Common Treatment Schemes of Thoracolumbar Spine Fractures Can Be Predicted With Magnetic Resonance Imaging 2002 ·Spine ·F. Cumhur Öner, A. P. G. van Gils, Joerg Faber, Wouter J.A. Dhert, A.J. Verbout	65
19	Shwachman-Diamond syndrome: early bone marrow transplantation in a high risk patient and new clues to pathogenesis 1999 ·European Journal of Pediatrics ·Joerg Faber, D R Betts, Roger Lauener, Reinhard Seger, (unknown), (unknown), Luis Filgueira	30
20	Three histopathological types of retinoblastoma and their relation to heredity and age of enucleation. 1996 ·Journal of Medical Genetics ·Annette C. Moll, Jan Willem Koten, (unknown), (unknown), K. E. W. P. Tan, (unknown), Joerg Faber, Willem Den Otter	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact